What drugs are used for tPA?

Tissue plasminogen activator (tPA) Drugs that are part of the tPA family include Activase (alteplase), Retavase (reteplase), and TNK-tPA (tenecteplase). Retavase is given to treat a heart attack or pulmonary thromboembolism.

What is a tPA procedure?

TPA is a thrombolytic or a “Clot Buster” drug. This clot buster is used to break-up the clot that is causing a blockage or disruption in the flow of blood to the brain and helps restore the blood flow to the area of the brain. It is given by intravenous (IV), not by mouth.

Is tPA given for heart attack?

Information. Thrombolytic medicines are approved for the emergency treatment of stroke and heart attack. The most commonly used drug for thrombolytic therapy is tissue plasminogen activator (tPA), but other drugs can do the same thing.

What are side effects of tPA?

Advertisement

• Bleeding from puncture sites and wounds.
• coughing up blood.
• difficulty with breathing or swallowing.
• headache.
• increased menstrual flow or vaginal bleeding.
• nosebleeds.
• paralysis.
• prolonged bleeding from cuts.

When do you give tPA to myocardial infarction?

FDA-approved indications for alteplase include pulmonary embolism, myocardial infarction with ST-segment elevation (STEMI), ischemic stroke when given within 3 hours of the start of symptoms, and re-establishment of patency in occluded intravenous (IV) catheters.

What are the side effects of tPA?

When is tPA not given?

Also, a clot-dissolving drug isn’t typically administered if the patient has one or more of the aforementioned medical issues. Also, thrombolytics should not be given to a stroke patient experiencing brain hemorrhage because increased bleeding could worsen the stroke.

Is tPA safe?

Guidelines recommend against the use of intravenous tPA (tissue-type plasminogen activator; IV tPA) in acute ischemic stroke patients with prior ischemic stroke within 3 months. However, there are limited data on the safety of IV tPA in this population.